MYD88 and rheumatoid arthritis: Finally, TLR4/MyD88 signalling in RA had previously been attributed solely to recognition of DAMPs in the joint65 and thus collectively, our findings shed new light on its pathogenic roles in initiation and progression of disease as well as emphasise its potential as a therapeutic target in RA.